Skip to content

Pulmonx Corporation LUNG Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction

Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction at other companies

Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$0-100%
American Resources Investment Trust Inc logo
American Resources Investment Trust IncINV
$0-100%
Blackstone Secured Lending Fund logo
Blackstone Secured Lending FundBXSL
$1.32M-29.2%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$30K-82.0%
Claritev Corporation logo
Claritev CorporationCTEV
$0-100%
Alliance Entertainment Holding Corporation logo
Alliance Entertainment Holding CorporationAENT
$1.96M

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's debt issuance costs incurred during noncash or partial noncash transaction.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's debt issuance costs incurred during noncash or partial noncash transaction?
Pulmonx Corporation (LUNG) reported debt issuance costs incurred during noncash or partial noncash transaction of $400K in Q1 2026.